Ane­mia spe­cial­ist Ake­bia merges with Keryx on the eve of a block­buster brawl with Fi­bro­Gen

Ake­bia is go­ing in­to its head-to-head late-stage fight with Fi­bro­Gen with a lit­tle more fire­pow­er.

Two months af­ter Keryx $KERX CEO Gre­go­ry Madi­son abrupt­ly re­signed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER